(Q34417640)

2 August 2017

1 reference

title

Calcineurin inhibitors and post-transplant hyperlipidaemias (English)

1 reference

2 August 2017

1 reference

R Moore

1

1 reference

2 August 2017

D Hernandez

series ordinal

2

1 reference

2 August 2017

H Valantine

series ordinal

3

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

24

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

755-766

1 reference

Changed composition of high-density lipoprotein subclasses HDL2 and HDL3 after renal transplantation.

2 August 2017

cites work

1 reference

12 December 2020

Evolution and etiology of cardiovascular diseases in renal transplant recipients

1 reference

12 December 2020

Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins.

1 reference

12 December 2020

Posttransplant medical complications

1 reference

12 December 2020

Hyperlipidemia in patients with chronic renal disease

1 reference

12 December 2020

[Influence of genetic variation at apoprotein A-1 gene promoter region on plasma lipid levels in heart transplantation patients]

1 reference

12 December 2020

Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.

1 reference

12 December 2020

Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Risk factors predicting chronic rejection of renal allografts

1 reference

12 December 2020

Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient

1 reference

12 December 2020

Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A

1 reference

12 December 2020

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

12 December 2020

Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients

1 reference

12 December 2020

Are lipid-dependent indicators of cardiovascular risk affected by renal transplantation?

1 reference

12 December 2020

Kidney transplantation from living unrelated donors

1 reference

12 December 2020

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

1 reference

12 December 2020

Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients

1 reference

12 December 2020

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group

1 reference

12 December 2020

The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial

1 reference

12 December 2020

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

1 reference

12 December 2020

Lipid Disorders in Renal Transplant Recipients

1 reference

12 December 2020

Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition

1 reference

12 December 2020

Hyperlipidemia in Stable Renal Transplant Recipients

1 reference

12 December 2020

Increased low density lipoprotein oxidation in stable kidney transplant recipients

1 reference

12 December 2020

Hyperlipidaemia in renal transplant patients.

1 reference

12 December 2020

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

12 December 2020

Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids

1 reference

12 December 2020

Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations

1 reference

12 December 2020

Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.

1 reference

12 December 2020

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

1 reference

12 December 2020

Explained and unexplained ischemic heart disease risk after renal transplantation

1 reference

12 December 2020

Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy

1 reference

12 December 2020

Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy

1 reference

12 December 2020

Efficacy and muscle safety of fluvastatin in cyclosporine-treated cardiac and renal transplant recipients: an exercise provocation test

1 reference

12 December 2020

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation

1 reference

12 December 2020

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

1 reference

12 December 2020

Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.

1 reference

12 December 2020

Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients

1 reference

12 December 2020

Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone

1 reference

12 December 2020

Effect of cyclosporin on plasma lipoproteins in bone marrow transplantation patients

1 reference

12 December 2020

The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients

1 reference

12 December 2020

Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients

1 reference

12 December 2020

Cardiovascular risk factors and diseases after renal transplantation

1 reference

12 December 2020

The effects of lipids on graft outcome

1 reference

12 December 2020

Metabolic problems in recipients of liver transplants

1 reference

12 December 2020

The role of lipoprotein abnormalities in chronic vascular rejection after kidney transplantation

1 reference

12 December 2020

Lipid abnormalities in black renal patients.

1 reference

12 December 2020

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

12 December 2020

Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506

1 reference

12 December 2020

Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation

1 reference

12 December 2020

Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results

1 reference

12 December 2020

Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.

1 reference

12 December 2020

Drugs causing dyslipoproteinemia

1 reference

12 December 2020

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

12 December 2020

Dyslipidemia in renal transplantation: a 3-year follow-up

1 reference

12 December 2020

Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a)

1 reference

12 December 2020

Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound

1 reference

12 December 2020

Diet, cholesterol and coronary heart disease. A perspective.

1 reference

12 December 2020

Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcome

1 reference

12 December 2020

Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin

1 reference

12 December 2020

Cardiovascular morbidity and risk factors in renal transplant patients

1 reference

12 December 2020

Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients.

1 reference

12 December 2020

Impact and management of hyperlipidemia posttransplantation

1 reference

12 December 2020

Lovastatin treatment of hypercholesterolemia in renal transplant recipients

1 reference

12 December 2020

Posttransplant hyperlipidemia: the treatment dilemma

1 reference

12 December 2020

Post-transplant hyperlipidaemia

1 reference

12 December 2020

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

12 December 2020

Lipid abnormalities in stable liver transplant recipients--effects of cyclosporin, tacrolimus, and steroids

1 reference

12 December 2020

Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet

1 reference

12 December 2020

Risk factors for cardiovascular disease after renal transplantation.

1 reference

12 December 2020

Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants

1 reference

12 December 2020

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

12 December 2020

A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients

1 reference

12 December 2020

Cholesterol as an independent predictor of outcome after renal transplantation

1 reference

12 December 2020

Impact of serum lipids on long-term graft and patient survival after renal transplantation

1 reference

12 December 2020

Effect of fluvastatin for safely loweringatherogenic lipids in renal transplant patients receiving cyclosporine

1 reference

12 December 2020

Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients

1 reference

12 December 2020

Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience

1 reference

12 December 2020

Lipid-lowering therapy in patients with renal disease

1 reference

12 December 2020

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

1 reference

12 December 2020

Risk factors for accelerated atherosclerosis in renal transplant recipients

1 reference

12 December 2020

Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection

1 reference

12 December 2020

Mechanisms of chronic rejection

1 reference

12 December 2020

Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients

1 reference

12 December 2020

Comparative tolerability of the HMG-CoA reductase inhibitors

1 reference

12 December 2020

The importance of obesity and hyperlipidaemia in patients with renal transplants

1 reference

12 December 2020

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

12 December 2020

Cardiovascular disease after renal transplantation

1 reference

12 December 2020

Cardiovascular disease after renal transplantation

1 reference

12 December 2020

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Persistent hyperlipidemia in renal transplant patients

1 reference

12 December 2020

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

12 December 2020

The effects of pravastatin on hyperlipidemia in renal transplant recipients

1 reference

12 December 2020

Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study

1 reference

12 December 2020

10.2165/00002018-200124100-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1012250533

0 references

1 reference